Profile of an Ideal Antianginal Agent
- 1 January 1989
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 38 (Supplement) , 1-8
- https://doi.org/10.2165/00003495-198900382-00003
Abstract
Many antianginal agents are available for the treatment of coronary artery disease. These agents act by influencing the determinants of myocardial oxygen supply and demand. The 3 main classes of...Keywords
This publication has 65 references indexed in Scilit:
- Silent Ischemia as a Marker for Early Unfavorable Outcomes in Patients with Unstable AnginaNew England Journal of Medicine, 1986
- Methemoglobin Levels Produced by Organic Nitrates in Patients with Coronary Artery DiseaseThe Journal of Clinical Pharmacology, 1984
- Newer concepts in the pathophysiology of ischemic heart diseaseAmerican Heart Journal, 1982
- The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response.Circulation, 1981
- β-Adrenoceptor Antagonists: New Drugs and New IndicationsNew England Journal of Medicine, 1981
- A Controlled Trial of Verapamil for Prinzmetal's Variant AnginaNew England Journal of Medicine, 1981
- Nifedipine Therapy for Coronary-Artery SpasmNew England Journal of Medicine, 1980
- Myocardial IschemiaNew England Journal of Medicine, 1977
- Reversal of Abnormal Platelet Aggregability and Change in Exercise Tolerance in Patients with Angina Pectoris Following Oral PropranololCirculation, 1974
- Studies on Cardiac Dimensions in Intact Unanesthetized ManCirculation, 1965